Trusted News Discovery Since 2008
{{/content}}
Preliminary Study Suggests Johnson & Johnson COVID Vaccine May Not Be As Effective Against Delta Variant
Video Credit: CBS 2 New York
Published on July 21, 2021 - Duration: 02:24s
Preliminary Study Suggests Johnson & Johnson COVID Vaccine May Not Be As Effective Against Delta Variant
The Delta variant of the coronavirus is spreading and is now responsible for 83% of new COVID cases in the United States.
A new study suggests the Johnson & Johnson vaccine may not be as effective fighting that variant; CBS2's Dr. Max Gomez reports.
You are here
Related videos from verified sources
Event In Brooklyn Promotes COVID Testing, Vaccinations 02:23
Video credit: CBS 2 New York - Published on July 31, 2021
Florida pharmacy makes COVID vaccine house calls 01:53
Video credit: Reuters - Politics - Published on July 31, 2021
Metro Public Health: Even with the spread of the delta variant, vaccines still work 01:58
Video credit: NewsChannel 5 Nashville - Published on July 31, 2021